InvestorsHub Logo

Doctor Detroit

10/10/17 3:39 PM

#12375 RE: turks #12374

My guess is they will learn their lesson from the Braeburn experience, and pick someone that already has an established buprenorphine sales channel. Probably someone on this list.

https://www.pharmacompass.com/eu-ctd-dossier-marketing-authorisation/buprenorphine-hydrochloride